NEOGENOMICS INC — Director's Dealing 2018

May 10, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2018-05-10

Reporting Person: ROSS STEVEN A (CIO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-10	Common Stock	M	33667	$4.78	Acquired	38167	Direct
2018-05-10	Common Stock	M	26666	$7.15	Acquired	64833	Direct
2018-05-10	Common Stock	M	21666	$7.52	Acquired	86499	Direct
2018-05-10	Common Stock	S	81999	$10.78	Disposed	4500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-10	Stock Option (Right to Buy)	$4.78	X	33667	Disposed	2020-05-06	Common Stock (33667.0)	Direct
2018-05-10	Stock Option (Right to Buy)	$7.15	X	26666	Disposed	2021-04-20	Common Stock (26666.0)	Direct
2018-05-10	Stock Option (Right to Buy)	$7.52	X	21666	Disposed	2022-04-28	Common Stock (21666.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4500	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$8.03	2023-02-26	Common Stock (72500.0)	72500	Direct

Footnotes

F1: On April 20, 2016, Mr. Ross was granted 40,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. Mr. Ross exercised 26,666 of these options in May 2018, leaving a balance of 13,334 options.

F2: On April 28, 2017, Mr. Ross was granted 65,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. Mr. Ross exercised 21,666 of these options in May 2018, leaving a balance of 43,334 options.

F3: On February 26, 2018, Mr. Ross was granted 72,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.